Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
24.7 EUR | -0.64% | -3.44% | -33.23% |
May. 31 | Galapagos, Adaptimmune to Jointly Develop Head, Neck Cancer Treatment | MT |
May. 31 | Galapagos, Adaptimmune Therapeutics Team Up to Evaluate Head and Neck Cancer Drug | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.23% | 1.77B | |
+51.85% | 57.87B | |
+41.76% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |
- Stock Market
- Equities
- GLPG Stock
- News Galapagos NV
- Galapagos Partners with Blood Centers of America to Decentralize CAR-T Cell Therapy Manufacture